Cantor Fitzgerald Raises Earnings Estimates for ALX Oncology
ALX Oncology Holdings Inc. (NASDAQ:ALXO – Free Report) – Equities research analysts at Cantor Fitzgerald lifted their FY2025 EPS estimates for shares of ALX Oncology in a research note issued on Tuesday, March 18th. Cantor Fitzgerald analyst L. Watsek now expects that the company will earn ($1.97) per share for the year, up from their […]
